3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Carcinoma, Non-Small-Cell Lung
22
Lung Neoplasms
10
Stomach Neoplasms
9
Neoplasm Metastasis
8
Esophageal Neoplasms
7
Breast Neoplasms
7
Colorectal Neoplasms
6
Nasopharyngeal Carcinoma
5
Leukemia, Myeloid, Acute
5
Triple Negative Breast Neoplasms
4
Small Cell Lung Carcinoma
4
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Neoplasms
4
Esophageal Squamous Cell Carcinoma
4
Adenocarcinoma Of Esophagus
4
Uterine Cervical Neoplasms
3
Fallopian Tube Neoplasms
3
Endometrial Neoplasms
3
Urinary Bladder Neoplasms
2
Rectal Neoplasms
2
Mouth Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma
2
Head and Neck Neoplasms
2
Glioma
2
Glioblastoma
2
Carcinoma, Squamous Cell
2
Carcinoma, Ovarian Epithelial
2
Anatomic Stage II Breast Cancer AJCC v8
2
Interventions
Cisplatin
6
Platinum
5
Pemetrexed
5
1,2-diaminocyclohexaneplatinum II citrate
5
pembrolizumab
4
atezolizumab
2
Radiotherapy
2
Radiation
2
Nivolumab
2
Ipilimumab
2
Gemcitabine
2
Cyclophosphamide
2
Carboplatin
2
tremelimumab
1
methoxyamine
1
fludarabine
1
decitabine and cedazuridine drug combination
1
cediranib
1
anetumab ravtansine
1
aldesleukin
1
Trioxsalen
1
Tissue Banks
1
Radiotherapy, Intensity-Modulated
1
Proton Therapy
1
Phototherapy
1
Photochemotherapy
1
Pharmacogenomic Testing
1
Pharmaceutical Preparations
1
Interleukin-2
1
Influenza Vaccines
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Drug Therapy
×
90 days
×
Clear all
NCT03710876
2026-04-21
INFINITE
Ferring Ventures Limited
Phase 3
Completed
53 enrolled
23 charts